Top Markets
Coin of the day
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
株式のランク #39771
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
株価
$0.26
最終同期: 2024-03-11
時価総額
$356.29K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 InVivo Therapeutics Holdings Corporation (NVIV)

カテゴリー

InVivo Therapeutics Holdings Corporation(NVIV)の配当利回りの履歴
InVivo Therapeutics Holdings Corporation(銘柄コード: NVIV)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
InVivo Therapeutics Holdings Corporation(NVIV)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)